Paxillin modulates squamous cancer cell adhesion and is important in pressure-augmented adhesion
✍ Scribed by William C. Conway; Jochem Van der Voort van Zyp; Vijayalakshmi Thamilselvan; Mary F. Walsh; David L. Crowe; Marc D. Basson
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 281 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Paxillin is an adapter protein regulating signaling and focal adhesion assembly that has been linked to malignant potential in many malignancies. Overexpression of paxillin has been noted in aggressive tumors. Integrin‐mediated binding through the focal adhesion complex is important in metastatic adhesion and is upregulated by extracellular pressure in malignant colonocytes through FAK and Src activation. Neither head and neck cancers nor paxillin have been studied in this regard. We hypothesized that paxillin would play a role in modulating squamous cancer adhesion both at baseline and under conditions of increased extracellular pressure. Using SCC25 tongue squamous cancer cells stably transfected with either an empty selection vector or paxillin expression and selection vectors, we studied adhesion to collagen, paxillin, FAK, and Src expression and phosphorylation in cells maintained for 30 min under ambient or 15 mmHg increased pressure conditions. Paxillin‐overexpressing cells exhibited adhesion 121 ± 2.9% of that observed in vector‐only cells (n = 6, P < 0.001) under ambient pressure. Paxillin‐overexpression reduced FAK phosphorylation. Pressure stimulated adhesion to 118 ± 2.3% (n = 6, P < 0.001) of baseline in vector‐only cells, similar to its effect in the parental line, and induced paxillin, FAK, and Src phosphorylation. However, increased pressure did not stimulate adhesion or phosphorylate paxillin, FAK, or Src further in paxillin‐overexpressing cells. Metastasizing squamous cancer cell adhesiveness may be increased by paxillin‐overexpression or by paxillin activation by extracellular pressure during surgical manipulation or growth within a constraining compartment. Targeting paxillin in patients with malignancy and minimal tumor manipulation during surgical resection may be important therapeutic adjuncts. J. Cell. Biochem. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Metastatic tumors are the primary cause of death in patients with breast cancer. Recent data indicate that the peroxisome proliferator‐activated receptor γ (PPARγ) ligands, thiazolidinediones (TZDs), possess anti‐invasive activities on human breast cancer cells. However, the effects of
## Background: Oral squamous cell carcinoma (oscc) is the most common malignancy of the oral cavity. however, the cellular and biochemical factors that underlie locoregional and distant spread of the disease are poorly understood. invasion of oscc requires multiple cellular events including dissolu